bioRxiv Science⌕ Search

Biology subjects

Obeng, E.

Publications and source records attributed to Obeng, E..

2 recordsLinked to original sources

Closing the loop: Teaching single-cell foundation models to learn from perturbations

The application of transfer learning models to large scale single-cell datasets has enabled the development of single-cell foundation models (scFMs) that can predict cellular responses to perturbations in silico. Although these predictions can be experimentally tested, current scFMs are unable to "close the loop" and learn from these experiments to create better predictions. Here, we introduce a "closed-loop" framework that extends the scFM by incorporating perturbation data during model fine-tuning. Our closed-loop model improves prediction accuracy, increasing positive predictive value in the setting of T-cell activation three-fold. We applied this model to RUNX1-familial platelet disorder, a rare pediatric blood disorder and identified two therapeutic targets (mTOR and CD74-MIF signaling axis) and two novel pathways (protein kinase C and phosphoinositide 3-kinase). This work establishes that iterative incorporation of experimental data to foundation models enhances biological predictions, representing a crucial step toward realizing the promise of "virtual cell" models for biomedical discovery.

bioinformatics↗

Senolytics Restore Hematopoietic Stem Cells Function in Sickle Cell Disease

Sickle Cell Disease (SCD) is a blood disorder affecting millions worldwide. Emerging evidence reveals that SCD pathophysiology increases risk of myeloid malignancies and hematopoietic stem cell (HSC) dysfunction, possibly due to pathological stress on bone marrow. To investigate this further, we interrogated mice and individuals with SCD and observed extended cell cycle times, oxidative stress, DNA damage, senescence, and dysregulation of molecular programs associated with these processes in bone marrow hematopoietic stem and progenitor cells (HSPCs). Human SCD HSPCs displayed poor hematopoietic potential ex vivo. SCD mice displayed a dramatic loss of transplantable bone marrow HSPCs, which was reversed upon treatment of SCD mice with the senolytic agent, ABT-263 (navitoclax). Thus, senolytics restore bone marrow function during SCD in mice and represent a novel strategy to improve bone marrow health in individuals with SCD and improve the safety of potentially curative gene therapies that utilize autologous HSPCs from individuals with SCD.

cell biology↗